Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NCS Multistage Holdings (NCSM) Cash & Equivalents (2016 - 2026)

NCS Multistage Holdings has reported Cash & Equivalents over the past 11 years, most recently at $34.5 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 49.84% year-over-year to $34.5 million; the TTM value through Mar 2026 reached $34.5 million, up 49.84%, while the annual FY2025 figure was $36.7 million, 41.9% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $34.5 million at NCS Multistage Holdings, down from $36.7 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $36.7 million in Q4 2025 and troughed at $9.9 million in Q3 2022.
  • A 5-year average of $19.5 million and a median of $16.2 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 46.45% in 2022 and later surged 65.0% in 2025.
  • Year by year, Cash & Equivalents stood at $16.2 million in 2022, then increased by 2.99% to $16.7 million in 2023, then skyrocketed by 54.78% to $25.9 million in 2024, then soared by 41.9% to $36.7 million in 2025, then decreased by 6.17% to $34.5 million in 2026.
  • Business Quant data shows Cash & Equivalents for NCSM at $34.5 million in Q1 2026, $36.7 million in Q4 2025, and $25.3 million in Q3 2025.